| 发明名称 |
Monohydrate Crystalline Form of 3-(5-(4-(3-Fluoropropyl)-Piperazin-1-YL)Benzimidazol-2-YL)-1-Azaazulen-2-One, Preparation, and Pharmaceutical Composition Thereof |
| 摘要 |
The disclosure is directed to a monohydrate crystalline form of 3-(5-(4-(3-fluoropropyl)piperazin-1-yl)benzimidazol-2-yl)-1-azaazulen-2-one, possessing diffraction peaks of about 12.9°, 15.9°, 17.9°, 21.2°, 22.9°, 23.5° and 24.5°. Its preparation method and pharmaceutical composition thereof are also provided. |
| 申请公布号 |
US2014171443(A1) |
申请公布日期 |
2014.06.19 |
| 申请号 |
US201313968089 |
申请日期 |
2013.08.15 |
| 申请人 |
INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE |
发明人 |
WEN Yen-Fang;TSAI Yuan-Jang;CHEN Wan-Ru;HU Tsan-Lin;TU Chia-Mu;LIU Chih-Peng |
| 分类号 |
C07D403/04 |
主分类号 |
C07D403/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A monohydrate crystalline form of 3-(5-(4-(3-fluoropropyl)piperazin-1-yl)benzimidazol-2-yl)-1-azaazulen-2-one, possesses diffraction peaks of about 12.9°, 15.9°, 17.9°, 21.2°, 22.9°, 23.5° and 24.5°.
|
| 地址 |
Hsinchu TW |
